Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: After skimming through all the messages ...

"There would now appear to be a strength which wasn't present during the re-exam, in my very humble opinion.."


I don't disagree, however, as seen by the small sampling below, TPL has falsely projected that strength many times.

----------------------------------------------

“Ever since the favorable Markman ruling issued earlier this summer, companies that rely on MMP Portfolio technologies have been showing increased interest to ensure that they and their customers are not hindered by supply chain disruptions.”

“By acting quickly to purchase a MMP license, Bosch will enjoy a real cost advantage over slower-moving competitors,”

“With various MMP claim constructions becoming clarified as the result of the June 15th ruling, our highly successful MMP licensing program continues to gain significant traction toward higher royalty rates.”

"Alliacense confirmed that subsequent licensees in segments where early tiers have been secured are subject to progressively higher royalty rates."

Share
New Message
Please login to post a reply